Structure

Physi-Chem Properties

Molecular Weight:  270.16
Volume:  298.613
LogP:  4.331
LogD:  3.724
LogS:  -4.907
# Rotatable Bonds:  0
TPSA:  37.3
# H-Bond Aceptor:  2
# H-Bond Donor:  1
# Rings:  3
# Heavy Atoms:  2

MedChem Properties

QED Drug-Likeness Score:  0.763
Synthetic Accessibility Score:  3.441
Fsp3:  0.5
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.924
MDCK Permeability:  1.8863876903196797e-05
Pgp-inhibitor:  0.379
Pgp-substrate:  0.002
Human Intestinal Absorption (HIA):  0.005
20% Bioavailability (F20%):  0.819
30% Bioavailability (F30%):  0.391

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.067
Plasma Protein Binding (PPB):  96.42304229736328%
Volume Distribution (VD):  0.984
Pgp-substrate:  4.3194355964660645%

ADMET: Metabolism

CYP1A2-inhibitor:  0.828
CYP1A2-substrate:  0.871
CYP2C19-inhibitor:  0.764
CYP2C19-substrate:  0.884
CYP2C9-inhibitor:  0.487
CYP2C9-substrate:  0.844
CYP2D6-inhibitor:  0.564
CYP2D6-substrate:  0.234
CYP3A4-inhibitor:  0.524
CYP3A4-substrate:  0.645

ADMET: Excretion

Clearance (CL):  11.421
Half-life (T1/2):  0.257

ADMET: Toxicity

hERG Blockers:  0.038
Human Hepatotoxicity (H-HT):  0.268
Drug-inuced Liver Injury (DILI):  0.279
AMES Toxicity:  0.178
Rat Oral Acute Toxicity:  0.42
Maximum Recommended Daily Dose:  0.852
Skin Sensitization:  0.193
Carcinogencity:  0.755
Eye Corrosion:  0.032
Eye Irritation:  0.898
Respiratory Toxicity:  0.921

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC254492

Natural Product ID:  NPC254492
Common Name*:   12-Hydroxy-13-Methyl-5,8,11,13-Podocarpatetraen-7-One
IUPAC Name:   (4aS)-6-hydroxy-1,1,4a,7-tetramethyl-3,4-dihydro-2H-phenanthren-9-one
Synonyms:  
Standard InCHIKey:  HSBIYLUTRHKDDM-GOSISDBHSA-N
Standard InCHI:  InChI=1S/C18H22O2/c1-11-8-12-13(9-14(11)19)18(4)7-5-6-17(2,3)16(18)10-15(12)20/h8-10,19H,5-7H2,1-4H3/t18-/m1/s1
SMILES:  O=C1C=C2C(C)(C)CCC[C@@]2(c2c1cc(C)c(c2)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3261110
PubChem CID:   90675898
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO17762 Crossopetalum gaumeri Species Celastraceae Eukaryota Roots Yucatan Peninsula n.a. PMID[24709561]
NPO17762 Crossopetalum gaumeri Species Celastraceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO17762 Crossopetalum gaumeri Species Celastraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO17762 Crossopetalum gaumeri Species Celastraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT165 Cell Line HeLa Homo sapiens IC50 = 45600.0 nM PMID[531344]
NPT165 Cell Line HeLa Homo sapiens IC50 = 39600.0 nM PMID[531344]
NPT189 Cell Line Vero Chlorocebus aethiops IC50 > 70000.0 nM PMID[531344]
NPT165 Cell Line HeLa Homo sapiens Ratio IC50 > 1.5 n.a. PMID[531344]
NPT165 Cell Line HeLa Homo sapiens Ratio IC50 > 1.8 n.a. PMID[531344]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 70000.0 nM PMID[531344]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC254492 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9917 High Similarity NPC72667
0.9754 High Similarity NPC171460
0.9752 High Similarity NPC84672
0.9752 High Similarity NPC176130
0.9752 High Similarity NPC69424
0.9752 High Similarity NPC78364
0.9667 High Similarity NPC199273
0.9516 High Similarity NPC108129
0.9512 High Similarity NPC96024
0.95 High Similarity NPC282577
0.944 High Similarity NPC471851
0.9435 High Similarity NPC276238
0.9435 High Similarity NPC303910
0.9417 High Similarity NPC154696
0.9355 High Similarity NPC3009
0.9291 High Similarity NPC138472
0.9291 High Similarity NPC78307
0.9291 High Similarity NPC477139
0.9268 High Similarity NPC123506
0.9219 High Similarity NPC202225
0.9174 High Similarity NPC259703
0.9174 High Similarity NPC32322
0.9154 High Similarity NPC36868
0.9141 High Similarity NPC111845
0.9024 High Similarity NPC176208
0.9008 High Similarity NPC53001
0.9008 High Similarity NPC475957
0.8976 High Similarity NPC117899
0.896 High Similarity NPC137750
0.8952 High Similarity NPC273683
0.8939 High Similarity NPC87723
0.8939 High Similarity NPC230811
0.8931 High Similarity NPC471670
0.8923 High Similarity NPC12070
0.8923 High Similarity NPC50924
0.8898 High Similarity NPC193203
0.8889 High Similarity NPC15837
0.8889 High Similarity NPC71610
0.8855 High Similarity NPC249272
0.8855 High Similarity NPC153088
0.8846 High Similarity NPC114183
0.8837 High Similarity NPC18798
0.8837 High Similarity NPC239134
0.88 High Similarity NPC471187
0.88 High Similarity NPC275145
0.879 High Similarity NPC162935
0.879 High Similarity NPC120545
0.879 High Similarity NPC249340
0.8788 High Similarity NPC474311
0.8779 High Similarity NPC270899
0.875 High Similarity NPC48248
0.875 High Similarity NPC229894
0.873 High Similarity NPC181334
0.8722 High Similarity NPC277559
0.872 High Similarity NPC307174
0.872 High Similarity NPC11250
0.872 High Similarity NPC91478
0.8712 High Similarity NPC283088
0.871 High Similarity NPC190971
0.871 High Similarity NPC241001
0.8702 High Similarity NPC4170
0.8702 High Similarity NPC53896
0.8692 High Similarity NPC93015
0.8692 High Similarity NPC17083
0.8692 High Similarity NPC244699
0.8692 High Similarity NPC164295
0.8682 High Similarity NPC34414
0.8682 High Similarity NPC146647
0.8676 High Similarity NPC308572
0.8672 High Similarity NPC471530
0.8667 High Similarity NPC471853
0.8667 High Similarity NPC242136
0.8651 High Similarity NPC174991
0.8647 High Similarity NPC191976
0.8626 High Similarity NPC165612
0.8615 High Similarity NPC253488
0.8615 High Similarity NPC27659
0.8613 High Similarity NPC100242
0.8594 High Similarity NPC160499
0.8593 High Similarity NPC242994
0.8593 High Similarity NPC138099
0.8583 High Similarity NPC173978
0.8583 High Similarity NPC231717
0.8583 High Similarity NPC142956
0.8583 High Similarity NPC164014
0.8582 High Similarity NPC471905
0.8582 High Similarity NPC49911
0.8571 High Similarity NPC477596
0.8571 High Similarity NPC121168
0.8571 High Similarity NPC22644
0.8571 High Similarity NPC80035
0.8561 High Similarity NPC225051
0.8561 High Similarity NPC59459
0.8561 High Similarity NPC52407
0.8561 High Similarity NPC267205
0.856 High Similarity NPC472981
0.855 High Similarity NPC476847
0.855 High Similarity NPC474517
0.855 High Similarity NPC72669
0.855 High Similarity NPC41847
0.854 High Similarity NPC477209
0.854 High Similarity NPC201297
0.854 High Similarity NPC248068
0.8538 High Similarity NPC99731
0.8538 High Similarity NPC25736
0.8537 High Similarity NPC174087
0.8529 High Similarity NPC181560
0.8529 High Similarity NPC169452
0.8527 High Similarity NPC19432
0.8525 High Similarity NPC322197
0.8519 High Similarity NPC4214
0.8519 High Similarity NPC13715
0.8507 High Similarity NPC7464
0.8507 High Similarity NPC472308
0.8507 High Similarity NPC254847
0.8504 High Similarity NPC198014
0.8496 Intermediate Similarity NPC166480
0.8496 Intermediate Similarity NPC282780
0.8496 Intermediate Similarity NPC477594
0.8492 Intermediate Similarity NPC253627
0.8489 Intermediate Similarity NPC478160
0.8485 Intermediate Similarity NPC58685
0.8485 Intermediate Similarity NPC183103
0.848 Intermediate Similarity NPC285829
0.848 Intermediate Similarity NPC206778
0.848 Intermediate Similarity NPC190501
0.848 Intermediate Similarity NPC478121
0.848 Intermediate Similarity NPC318552
0.8473 Intermediate Similarity NPC55949
0.8462 Intermediate Similarity NPC282923
0.8455 Intermediate Similarity NPC477453
0.845 Intermediate Similarity NPC474737
0.845 Intermediate Similarity NPC306765
0.845 Intermediate Similarity NPC3224
0.8444 Intermediate Similarity NPC119542
0.8444 Intermediate Similarity NPC53206
0.8444 Intermediate Similarity NPC53414
0.8438 Intermediate Similarity NPC68756
0.8438 Intermediate Similarity NPC152525
0.8433 Intermediate Similarity NPC290803
0.8433 Intermediate Similarity NPC258502
0.843 Intermediate Similarity NPC250323
0.8425 Intermediate Similarity NPC300274
0.8421 Intermediate Similarity NPC115458
0.8421 Intermediate Similarity NPC49742
0.8421 Intermediate Similarity NPC263817
0.8417 Intermediate Similarity NPC196941
0.8417 Intermediate Similarity NPC309169
0.8413 Intermediate Similarity NPC216216
0.8409 Intermediate Similarity NPC291001
0.8409 Intermediate Similarity NPC85342
0.8406 Intermediate Similarity NPC19631
0.8406 Intermediate Similarity NPC135524
0.8406 Intermediate Similarity NPC239136
0.8406 Intermediate Similarity NPC184935
0.8406 Intermediate Similarity NPC193555
0.84 Intermediate Similarity NPC42657
0.84 Intermediate Similarity NPC473767
0.8397 Intermediate Similarity NPC92624
0.8394 Intermediate Similarity NPC476534
0.8382 Intermediate Similarity NPC297797
0.8382 Intermediate Similarity NPC28592
0.8382 Intermediate Similarity NPC245760
0.8382 Intermediate Similarity NPC157284
0.8382 Intermediate Similarity NPC477849
0.8382 Intermediate Similarity NPC46242
0.8382 Intermediate Similarity NPC165191
0.8382 Intermediate Similarity NPC61398
0.8382 Intermediate Similarity NPC23667
0.8382 Intermediate Similarity NPC51531
0.8382 Intermediate Similarity NPC469857
0.8382 Intermediate Similarity NPC473779
0.8382 Intermediate Similarity NPC289358
0.8382 Intermediate Similarity NPC42384
0.8382 Intermediate Similarity NPC416
0.8382 Intermediate Similarity NPC149773
0.8382 Intermediate Similarity NPC50615
0.8382 Intermediate Similarity NPC114333
0.8382 Intermediate Similarity NPC91887
0.8382 Intermediate Similarity NPC473479
0.8382 Intermediate Similarity NPC5014
0.8372 Intermediate Similarity NPC477454
0.8372 Intermediate Similarity NPC87985
0.837 Intermediate Similarity NPC315275
0.837 Intermediate Similarity NPC118919
0.837 Intermediate Similarity NPC155211
0.8369 Intermediate Similarity NPC5568
0.8359 Intermediate Similarity NPC375356
0.8357 Intermediate Similarity NPC12402
0.8347 Intermediate Similarity NPC260323
0.8347 Intermediate Similarity NPC176279
0.8346 Intermediate Similarity NPC295034
0.8346 Intermediate Similarity NPC312560
0.8346 Intermediate Similarity NPC175738
0.8345 Intermediate Similarity NPC478164
0.8333 Intermediate Similarity NPC204045
0.8333 Intermediate Similarity NPC259942
0.8333 Intermediate Similarity NPC246638
0.8333 Intermediate Similarity NPC95172
0.8333 Intermediate Similarity NPC136588

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC254492 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8699 High Similarity NPD4196 Clinical (unspecified phase)
0.8629 High Similarity NPD2932 Approved
0.8507 High Similarity NPD1509 Clinical (unspecified phase)
0.848 Intermediate Similarity NPD3019 Approved
0.8346 Intermediate Similarity NPD1201 Approved
0.8231 Intermediate Similarity NPD1470 Approved
0.816 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.8156 Intermediate Similarity NPD7390 Discontinued
0.8043 Intermediate Similarity NPD5408 Approved
0.8043 Intermediate Similarity NPD5404 Approved
0.8043 Intermediate Similarity NPD5405 Approved
0.8043 Intermediate Similarity NPD5406 Approved
0.8 Intermediate Similarity NPD5951 Approved
0.7943 Intermediate Similarity NPD7003 Approved
0.7863 Intermediate Similarity NPD3972 Approved
0.7846 Intermediate Similarity NPD3023 Approved
0.7846 Intermediate Similarity NPD3026 Approved
0.7829 Intermediate Similarity NPD3025 Approved
0.7829 Intermediate Similarity NPD3024 Approved
0.7769 Intermediate Similarity NPD7163 Clinical (unspecified phase)
0.7687 Intermediate Similarity NPD1164 Approved
0.7635 Intermediate Similarity NPD7458 Discontinued
0.7609 Intermediate Similarity NPD6663 Approved
0.7606 Intermediate Similarity NPD2346 Discontinued
0.7603 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7589 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.7586 Intermediate Similarity NPD3300 Phase 2
0.7581 Intermediate Similarity NPD2342 Discontinued
0.7574 Intermediate Similarity NPD5736 Approved
0.7569 Intermediate Similarity NPD8166 Discontinued
0.7559 Intermediate Similarity NPD7635 Approved
0.7557 Intermediate Similarity NPD1651 Approved
0.7554 Intermediate Similarity NPD943 Approved
0.7535 Intermediate Similarity NPD6100 Approved
0.7535 Intermediate Similarity NPD6099 Approved
0.7535 Intermediate Similarity NPD2935 Discontinued
0.752 Intermediate Similarity NPD6831 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD4626 Approved
0.75 Intermediate Similarity NPD3412 Clinical (unspecified phase)
0.7481 Intermediate Similarity NPD3091 Approved
0.7481 Intermediate Similarity NPD1283 Approved
0.7479 Intermediate Similarity NPD1809 Phase 2
0.7447 Intermediate Similarity NPD1607 Approved
0.744 Intermediate Similarity NPD9265 Clinical (unspecified phase)
0.741 Intermediate Similarity NPD3764 Approved
0.7407 Intermediate Similarity NPD1755 Approved
0.74 Intermediate Similarity NPD3226 Approved
0.7379 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7372 Intermediate Similarity NPD2798 Approved
0.7368 Intermediate Similarity NPD4059 Approved
0.7361 Intermediate Similarity NPD2344 Approved
0.7343 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7343 Intermediate Similarity NPD2799 Discontinued
0.7333 Intermediate Similarity NPD844 Approved
0.7329 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD4628 Phase 3
0.7329 Intermediate Similarity NPD3750 Approved
0.7323 Intermediate Similarity NPD4750 Phase 3
0.732 Intermediate Similarity NPD7819 Suspended
0.7315 Intermediate Similarity NPD6273 Approved
0.7305 Intermediate Similarity NPD1240 Approved
0.7295 Intermediate Similarity NPD3020 Approved
0.7273 Intermediate Similarity NPD3495 Discontinued
0.7273 Intermediate Similarity NPD288 Approved
0.7261 Intermediate Similarity NPD6959 Discontinued
0.7259 Intermediate Similarity NPD3092 Approved
0.7259 Intermediate Similarity NPD1281 Approved
0.725 Intermediate Similarity NPD1432 Clinical (unspecified phase)
0.7248 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7248 Intermediate Similarity NPD2532 Approved
0.7248 Intermediate Similarity NPD2533 Approved
0.7248 Intermediate Similarity NPD2534 Approved
0.7236 Intermediate Similarity NPD289 Clinical (unspecified phase)
0.7226 Intermediate Similarity NPD1876 Approved
0.7222 Intermediate Similarity NPD1510 Phase 2
0.7218 Intermediate Similarity NPD9545 Approved
0.7215 Intermediate Similarity NPD6232 Discontinued
0.7214 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7214 Intermediate Similarity NPD7008 Discontinued
0.7209 Intermediate Similarity NPD1609 Clinical (unspecified phase)
0.7206 Intermediate Similarity NPD4878 Approved
0.7192 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.719 Intermediate Similarity NPD2859 Approved
0.719 Intermediate Similarity NPD2860 Approved
0.7188 Intermediate Similarity NPD7473 Discontinued
0.7171 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7164 Intermediate Similarity NPD5691 Approved
0.7162 Intermediate Similarity NPD2309 Approved
0.7143 Intermediate Similarity NPD7610 Discontinued
0.7143 Intermediate Similarity NPD2800 Approved
0.7133 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7132 Intermediate Similarity NPD4141 Clinical (unspecified phase)
0.712 Intermediate Similarity NPD1931 Clinical (unspecified phase)
0.712 Intermediate Similarity NPD1930 Approved
0.712 Intermediate Similarity NPD1929 Approved
0.7113 Intermediate Similarity NPD8032 Phase 2
0.7111 Intermediate Similarity NPD2286 Discontinued
0.7111 Intermediate Similarity NPD3095 Discontinued
0.7109 Intermediate Similarity NPD74 Approved
0.7109 Intermediate Similarity NPD9266 Approved
0.7107 Intermediate Similarity NPD2934 Approved
0.7107 Intermediate Similarity NPD2933 Approved
0.7097 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD6651 Approved
0.7071 Intermediate Similarity NPD4208 Discontinued
0.7068 Intermediate Similarity NPD9493 Approved
0.7054 Intermediate Similarity NPD3021 Approved
0.7054 Intermediate Similarity NPD3022 Approved
0.705 Intermediate Similarity NPD3094 Phase 2
0.7047 Intermediate Similarity NPD7910 Clinical (unspecified phase)
0.7042 Intermediate Similarity NPD2313 Discontinued
0.7031 Intermediate Similarity NPD9263 Approved
0.7031 Intermediate Similarity NPD9264 Approved
0.7031 Intermediate Similarity NPD9267 Approved
0.7029 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD845 Approved
0.7016 Intermediate Similarity NPD2066 Phase 3
0.7013 Intermediate Similarity NPD4380 Phase 2
0.6994 Remote Similarity NPD5844 Phase 1
0.6986 Remote Similarity NPD3748 Approved
0.6986 Remote Similarity NPD4308 Phase 3
0.6985 Remote Similarity NPD1751 Approved
0.6966 Remote Similarity NPD4097 Suspended
0.6963 Remote Similarity NPD7009 Phase 2
0.6959 Remote Similarity NPD1549 Phase 2
0.6957 Remote Similarity NPD9269 Phase 2
0.695 Remote Similarity NPD9494 Approved
0.6947 Remote Similarity NPD6124 Clinical (unspecified phase)
0.6944 Remote Similarity NPD2979 Phase 3
0.6943 Remote Similarity NPD8438 Clinical (unspecified phase)
0.6943 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6939 Remote Similarity NPD2796 Approved
0.6929 Remote Similarity NPD2797 Approved
0.6929 Remote Similarity NPD1237 Approved
0.6923 Remote Similarity NPD3268 Approved
0.6912 Remote Similarity NPD4093 Discontinued
0.6912 Remote Similarity NPD9268 Approved
0.6903 Remote Similarity NPD6599 Discontinued
0.6901 Remote Similarity NPD4207 Discontinued
0.6892 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6892 Remote Similarity NPD1471 Phase 3
0.6892 Remote Similarity NPD1550 Clinical (unspecified phase)
0.689 Remote Similarity NPD6020 Phase 2
0.6887 Remote Similarity NPD7236 Approved
0.6887 Remote Similarity NPD6884 Clinical (unspecified phase)
0.6861 Remote Similarity NPD4589 Approved
0.6859 Remote Similarity NPD7411 Suspended
0.6857 Remote Similarity NPD6696 Suspended
0.6855 Remote Similarity NPD7075 Discontinued
0.6853 Remote Similarity NPD4625 Phase 3
0.6842 Remote Similarity NPD7159 Clinical (unspecified phase)
0.6842 Remote Similarity NPD1511 Approved
0.6842 Remote Similarity NPD1241 Discontinued
0.6835 Remote Similarity NPD1608 Approved
0.6831 Remote Similarity NPD3636 Approved
0.6831 Remote Similarity NPD3635 Approved
0.6831 Remote Similarity NPD3637 Approved
0.6829 Remote Similarity NPD7177 Discontinued
0.6828 Remote Similarity NPD4060 Phase 1
0.6824 Remote Similarity NPD4476 Approved
0.6824 Remote Similarity NPD4477 Approved
0.6815 Remote Similarity NPD7325 Clinical (unspecified phase)
0.6815 Remote Similarity NPD1934 Approved
0.6812 Remote Similarity NPD4879 Approved
0.6797 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6795 Remote Similarity NPD7028 Phase 2
0.6791 Remote Similarity NPD497 Approved
0.6786 Remote Similarity NPD3534 Clinical (unspecified phase)
0.6786 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6784 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6783 Remote Similarity NPD2605 Approved
0.6783 Remote Similarity NPD2606 Approved
0.6781 Remote Similarity NPD230 Phase 1
0.6779 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6774 Remote Similarity NPD7239 Suspended
0.6772 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6772 Remote Similarity NPD940 Approved
0.6772 Remote Similarity NPD2801 Approved
0.6772 Remote Similarity NPD1932 Approved
0.6772 Remote Similarity NPD846 Approved
0.6765 Remote Similarity NPD8150 Discontinued
0.6763 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6761 Remote Similarity NPD2194 Approved
0.6761 Remote Similarity NPD2195 Approved
0.6761 Remote Similarity NPD6917 Clinical (unspecified phase)
0.6761 Remote Similarity NPD4624 Approved
0.6753 Remote Similarity NPD1512 Approved
0.675 Remote Similarity NPD3749 Approved
0.6739 Remote Similarity NPD1778 Approved
0.6736 Remote Similarity NPD5155 Approved
0.6736 Remote Similarity NPD5156 Approved
0.6721 Remote Similarity NPD7609 Phase 3
0.6719 Remote Similarity NPD9261 Approved
0.6716 Remote Similarity NPD496 Approved
0.6716 Remote Similarity NPD495 Approved
0.6716 Remote Similarity NPD498 Approved
0.6713 Remote Similarity NPD4212 Discontinued
0.6712 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6712 Remote Similarity NPD3620 Phase 2
0.6712 Remote Similarity NPD4140 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data